Mycophenolate mofetil and Lacrimation increased - a phase IV clinical study of FDA data

Summary:

Lacrimation increased is reported as a side effect among people who take Mycophenolate mofetil (mycophenolate mofetil), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Rapamune, and have Pemphigoid.

The phase IV clinical study analyzes which people have Lacrimation increased when taking Mycophenolate mofetil. It is created by eHealthMe based on reports of 93,176 people who have side effects when taking Mycophenolate mofetil from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,461 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Lacrimation increased?

Lacrimation increased is found to be associated with 1,340 drugs and 1,798 conditions by eHealthMe. Check the latest studies of Lacrimation increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

93,176 people reported to have side effects when taking Mycophenolate mofetil.
Among them, 15 people (0.02%) have Lacrimation increased.

Could Mycophenolate mofetil cause Lacrimation increased?

Among these 15 people:

How long have people been on Mycophenolate mofetil when they have Lacrimation increased? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Lacrimation increased when taking Mycophenolate mofetil? *

  • female: 53.85 %
  • male: 46.15 %

What is the age of people who have Lacrimation increased when taking Mycophenolate mofetil? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 11.11 %
  • 20-29: 0.0 %
  • 30-39: 22.22 %
  • 40-49: 0.0 %
  • 50-59: 11.11 %
  • 60+: 55.56 %

What are other drugs people take besides Mycophenolate mofetil? *

  1. Vitamin D3: 3 people, 20.00%
  2. Rapamune: 3 people, 20.00%
  3. Zosyn: 2 people, 13.33%
  4. Methylprednisolone: 2 people, 13.33%
  5. Cetirizine Hydrochloride: 2 people, 13.33%
  6. Ciclosporin: 2 people, 13.33%
  7. Cymbalta: 2 people, 13.33%
  8. Diflucan: 2 people, 13.33%
  9. Diphenhydramine Hydrochloride: 2 people, 13.33%
  10. Doxycycline Hyclate: 2 people, 13.33%

What are other side effects people have besides Lacrimation increased? *

  1. Fever: 4 people, 26.67%
  2. Hypotension (abnormally low blood pressure): 3 people, 20.00%
  3. Dry Eyes (lack of adequate tears): 3 people, 20.00%
  4. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 3 people, 20.00%
  5. Diarrhea: 3 people, 20.00%
  6. Human Herpesvirus 6 Infection: 3 people, 20.00%
  7. Arrhythmias (irregular heartbeat): 3 people, 20.00%
  8. Dermatitis Exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss): 3 people, 20.00%
  9. Urine Output Decreased: 3 people, 20.00%
  10. Acute Respiratory Failure: 3 people, 20.00%

What are the existing conditions these people have? *

  1. Pemphigoid (tense blisters on the skin): 3 people, 20.00%
  2. Thrombophlebitis Migrans (development of recurrent (i.e. migratory) superficial thrombophlebitis): 2 people, 13.33%
  3. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 13.33%
  4. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 13.33%
  5. Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 2 people, 13.33%
  6. Psoriasis (immune-mediated disease that affects the skin): 1 person, 6.67%
  7. Lymphocytic Leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes): 1 person, 6.67%
  8. Itching: 1 person, 6.67%
  9. High Blood Cholesterol: 1 person, 6.67%
  10. Haemochromatosis (body to absorb more iron than usual from food): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and have Lacrimation increased?

- Check whether Lacrimation increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mycophenolate mofetil:

Lacrimation increased treatments and more:

How severe was Lacrimation increased and when was it recovered:

Expand to all the drugs that have ingredients of mycophenolate mofetil:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lacrimation increased:

Browse all the conditions that are associated with Lacrimation increased:


How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Mycophenolate mofetil) and Mycophenolate mofetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: